APP and Alzheimer disease: Metformin improved cognitive deficits in the hippocampus of the APP/PS1 mice model of AD via promoting Chaperone-mediated autophagy (CMA)-activated degradation of Aβ, which suggested that it might be a possible therapy for AD (Xu et al., 2021).